{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:32:34Z","timestamp":1793277154507,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.xphs.2022.10.033","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T21:36:59Z","timestamp":1667511419000},"page":"1216-1219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Trace Aldehydes in Solid Oral Dosage Forms as Catalysts for Nitrosating Secondary Amines"],"prefix":"10.1016","volume":"112","author":[{"given":"Paul","family":"Harmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2022.10.033_bib0001","series-title":"Guidance for Industry Revision 1","year":"2021"},{"key":"10.1016\/j.xphs.2022.10.033_bib0002","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/cts.12995","article-title":"Is this the end for ranitidine? NDMA presence continues to confound","volume":"14","author":"Wagner","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.xphs.2022.10.033_bib0003","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/acs.oprd.0c00462","article-title":"Ranitidine-investigations into the root cause for the presence of NNitrosoN,Ndimethylamine in ranitidine hydrochloride drug substances and associated drug products","volume":"24","author":"King","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.10.033_bib0004","first-page":"1","article-title":"A nitrite excipient database: a useful tool to support N-Nitrosamine risk assessments for drug products","volume":"000","author":"Boetzel","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.10.033_bib0005","unstructured":"Lhasa limited, Nitrites in excipient database. Available athttps:\/\/www.lhasalimited.org\/news\/nitrites-in-excipients-data-release-supporting-more-scientifically-driven-nitrosamine-risk-assessments\/11537. Accessed November 9, 2022"},{"key":"10.1016\/j.xphs.2022.10.033_bib0006","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1021\/acs.oprd.0c00224","article-title":"Potential for the formation of N-nitrosamines during the manufacture of active pharmaceutical ingredients: an assessment of the risk posed by trace nitrite in water","volume":"24","author":"Ashworth","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.10.033_bib0007","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/acs.oprd.0c00323","article-title":"Pathways for NNitroso compound formation: secondary amines and beyond","volume":"24","author":"Lopez-Rodr\u00edguez","year":"2020","journal-title":"Org Process Res Dev"},{"key":"10.1016\/j.xphs.2022.10.033_bib0008","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1126\/science.181.4106.1245","article-title":"N-Nitrosation by nitrite ion in neutral and basic medium","volume":"181","author":"Keeper","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.xphs.2022.10.033_bib0009","series-title":"Environmental N-Nitroso Compounds, Analysis and Formation","first-page":"141","article-title":"Nitrosamine formation in the presence of carbonyl compounds","author":"Archer","year":"1976"},{"key":"10.1016\/j.xphs.2022.10.033_bib0010","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1039\/p29840001963","article-title":"Nitrite ion as a nitrosating reagent. nitrosation of \u0301 morpholine and diethylamine in the presence of formaldehyde","volume":"2","author":"Casado","year":"1984","journal-title":"J Chem Soc Perkin Trans"},{"issue":"A","key":"10.1016\/j.xphs.2022.10.033_bib0011","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jp8061674","article-title":"Theoretical investigation of N-nitrosodimethylamine formation from dimethylamine nitrosation catalyzed by carbonyl compounds","volume":"113","author":"Lv","year":"2009","journal-title":"J Phys Chem"},{"issue":"41","key":"10.1016\/j.xphs.2022.10.033_bib0012","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jpba.2005.12.033","article-title":"Simultaneous determination of formic acid and formaldehyde in pharmaceutical excipients using headspace GC\/MS","author":"Del Barrio","year":"2006","journal-title":"J Pharm And Biomed Anal"},{"key":"10.1016\/j.xphs.2022.10.033_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2005.10.084","article-title":"Detection and quantification of low-molecular-weight aldehydes in pharmaceutical excipients by headspace gas chromatography","volume":"1104","author":"Li","year":"2006","journal-title":"J Chromatography A"},{"issue":"4","key":"10.1016\/j.xphs.2022.10.033_bib0014","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","article-title":"Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility","volume":"12","author":"Wu","year":"2011","journal-title":"AAPS PharmaSciTech"},{"key":"10.1016\/j.xphs.2022.10.033_bib0015","first-page":"72","article-title":"Stress testing: the chemistry of drug degradation","author":"Baertschi","year":"2011","journal-title":"Pharmaceutical Stress Testing"},{"issue":"2","key":"10.1016\/j.xphs.2022.10.033_bib0016","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1081\/PDT-120030249","article-title":"Influence of formaldehyde impurity in polysorbate 80 and PEG 300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product","volume":"9","author":"Nassar","year":"2004","journal-title":"Pharmaceut Dev Tech"},{"key":"10.1016\/j.xphs.2022.10.033_bib0017","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10837450802244918","article-title":"Identification and control of a degradation product in avapro film-coated tablet: low dose formulation","volume":"13","author":"Wang","year":"2008","journal-title":"Pharm Dev Tech"},{"issue":"4","key":"10.1016\/j.xphs.2022.10.033_bib0018","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jps.21119","article-title":"N-methylation and N-formylation of a secondary amine drug (Varenicline) in an osmotic tablet","volume":"97","author":"Waterman","year":"2008","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2022.10.033_bib0019","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1208\/s12249-014-0231-7","article-title":"Surface acidity and solid-state compatibility of excipients with an acid sensitive API: case study of atorvastatin calcium","volume":"16","author":"Govindarajan","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2022.10.033_bib0020","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jps.21052","article-title":"Measurement of surface pH of pharmaceutical solids: a critical evaluation of indicator dye-sorption method and its comparison with slurry pH method","volume":"97","author":"Pudipeddi","year":"2008","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2022.10.033_bib0021","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600820611","article-title":"Effects of temperature and humidity on the solid-state chemical stability of ranitidine hydrochloride","volume":"82","author":"Teraoka","year":"1993","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2022.10.033_bib0022","article-title":"Ranitidine: A proposed mechanistic rationale for NDMA formation and a possible control strategy","author":"Harmon","year":"2022","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922005111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922005111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:41:27Z","timestamp":1758361287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922005111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0022354922005111"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.10.033","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trace Aldehydes in Solid Oral Dosage Forms as Catalysts for Nitrosating Secondary Amines","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}